OP-1 Augments Glucocorticoid-inhibited Fracture Healing in a Rat Fracture Model

被引:11
作者
Gilley, Robert S. [1 ,2 ]
Wallace, Larry J. [2 ]
Bourgeault, Craig A. [3 ,4 ]
Kidder, Louis S. [3 ,4 ]
Bechtold, Joan E. [3 ,4 ]
机构
[1] Univ Penn, Sch Vet Med, Dept Clin Studies, Philadelphia, PA 19104 USA
[2] Univ Minnesota, Coll Vet Med, Dept Small Anim Clin Sci, St Paul, MN 55108 USA
[3] Midwest Orthopaed Res Fdn, Orthopaed Biomech Lab, Minneapolis, MN USA
[4] Minneapolis Med Res Fdn Inc, Minneapolis, MN USA
关键词
BONE MORPHOGENETIC PROTEIN-2; OSTEOBLAST DIFFERENTIATION; OSTEOGENIC PROTEIN-1; SEGMENTAL DEFECTS; EXTRACELLULAR-MATRIX; INDUCED OSTEOPOROSIS; PREDNISOLONE; REPAIR; FUSION; CALLUS;
D O I
10.1007/s11999-009-0782-1
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
100224 [整形外科学];
摘要
Glucocorticoids inhibit bone remodeling and fracture healing. We sought to determine whether osteogenic protein 1 (OP-1) can overcome this inhibition in a closed fracture model in the rat. Time-released prednisolone or placebo pellets were implanted subcutaneously; closed femoral fractures were created 2 weeks later in rats. Fractures received sham, OP-1 and collagen, or collagen-only implants. Femurs were harvested at 3, 10, 21, 28, and 42 days postfracture. Fractures were examined radiographically for amount of hard callus; mechanically for torque and stiffness (also expressed as a percentage of the contralateral intact femur); and histomorphometrically for amount of cartilaginous and noncartilaginous soft callus, hard callus, and total callus. Glucocorticoid administration inhibited fracture healing. The application of a devitalized Type I collagen matrix mitigated the inhibitory effects of prednisolone on fracture healing However, further increases in indices of fracture healing were observed when OP-1 was added to the collagen matrix compared with collagen alone. OP-1 and collagen was more effective than collagen alone.
引用
收藏
页码:3104 / 3112
页数:9
相关论文
共 56 条
[1]
BLUNT JW, 1950, P SOC EXP BIOL MED, V73, P678
[2]
BOLANDER ME, 1992, P SOC EXP BIOL MED, V200, P165
[3]
THE USE OF DEMINERALIZED BONE-MATRIX IN THE REPAIR OF SEGMENTAL DEFECTS - AUGMENTATION WITH EXTRACTED MATRIX PROTEINS AND A COMPARISON WITH AUTOLOGOUS GRAFTS [J].
BOLANDER, ME ;
BALIAN, G .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1986, 68A (08) :1264-1274
[4]
BONNARENS F, 1984, Journal of Orthopaedic Research, V2, P97, DOI 10.1002/jor.1100020115
[5]
Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens:: current questions and tentative answers in rheumatology [J].
Buttgereit, F ;
da Silva, JAP ;
Boers, M ;
Burmester, GR ;
Cutolo, M ;
Jacobs, J ;
Kirwan, J ;
Köhler, L ;
van Riel, P ;
Vischer, T ;
Bijlsma, JWJ .
ANNALS OF THE RHEUMATIC DISEASES, 2002, 61 (08) :718-722
[6]
Reduction in transforming growth factor β receptor I expression and transcription factor CBFa1 on bone cells by glucocorticoid [J].
Chang, DJ ;
Ji, C ;
Kim, KK ;
Casinghino, S ;
McCarthy, TL ;
Centrella, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (09) :4892-4896
[7]
Osteogenic protein-1 induced bone formation in an infected segmental defect in the rat femur [J].
Chen, XQ ;
Kidder, LS ;
Lew, WD .
JOURNAL OF ORTHOPAEDIC RESEARCH, 2002, 20 (01) :142-150
[8]
Cochran DL, 1997, INT J ORAL MAX IMPL, V12, P739
[9]
COOK SD, 1994, CLIN ORTHOP RELAT R, P302
[10]
THE EFFECT OF RECOMBINANT HUMAN OSTEOGENIC PROTEIN-1 ON HEALING OF LARGE SEGMENTAL BONE DEFECTS [J].
COOK, SD ;
BAFFES, GC ;
WOLFE, MW ;
SAMPATH, TK ;
RUEGER, DC ;
WHITECLOUD, TS .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1994, 76A (06) :827-838